Investigation of a Kv1.3 Potassium Channel Blocker as Immunosuppressive Agent in Reconstructive Transplantation

被引：0
|
作者：
Hautz, Theresa [1 ]
Grahammer, Johanna [1 ]
Krapf, Christoph [1 ]
Zelger, Bettina [2 ]
Seger, Christoph [3 ]
Pfisterer, Hartwig [3 ]
Brandacher, Gerald [1 ,4 ]
Ollinger, Robert [1 ]
Lee, Andrew [4 ]
Margreiter, Raimund [1 ]
Pratschke, Johann [1 ]
Glossmann, Hartmut [5 ]
Schneeberger, Stefan [1 ,4 ]
机构：
[1] Innsbruck Med Univ, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria
[2] Innsbruck Med Ctr, Dept Pathol, Innsbruck, Austria
[3] Inst Med & Chem, Diagnost Lab, Innsbruck, Austria
[4] Univ Pittsburgh, Med Ctr, Div Plast Surg, Pittsburgh, PA 15260 USA
[5] Innsbruck Med Univ, Inst Biochem Pharmacol, Innsbruck, Austria
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [1] Enantioselective total synthesis of (-)-candelalide A, a novel blocker of the voltage-gated potassium channel Kv1.3 for an immunosuppressive agent
    Watanabe, K
    Iwasaki, K
    Abe, T
    Inoue, M
    Ohkubo, K
    Suzuki, T
    Katoh, T
    ORGANIC LETTERS, 2005, 7 (17) : 3745 - 3748
  • [2] Human T cell kv1.3 potassium channel blocker
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1997, 2 (08) : 352 - 353
  • [3] Tyrosine phosphorylation of the Kv1.3 potassium channel
    Holmes, TC
    Fadool, DA
    Levitan, IB
    JOURNAL OF NEUROSCIENCE, 1996, 16 (05): : 1581 - 1590
  • [4] INVESTIGATION OF THE EFFECT OF LOCAL INTRA-GRAFT TREATMENT WITH LYMPHOCYTE MIGRATORY BLOCKERS AND A KV1.3 POTASSIUM CHANNEL BLOCKER TOGETHER WITH SHORT-TERM SYSTEMIC IMMUNOSUPPRESSION ON SKIN REJECTION IN RECONSTRUCTIVE TRANSPLANTATION
    Hautz, T.
    Pulikkottil, B.
    Grahammer, J.
    Jindal, R.
    Krapf, C.
    Gorantla, V. S.
    Zelger, B.
    Brandacher, G.
    Petzelbauer, P.
    Schoen, M. P.
    Glossmann, H.
    Margreiter, R.
    Lee, A. W.
    Pratschke, J.
    Schneeberger, S.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 54 - 54
  • [5] Immunosuppressive effects of a Kv1.3 inhibitor
    Shah, K
    Blake, JT
    Huang, C
    Fischer, P
    Koo, GC
    CELLULAR IMMUNOLOGY, 2003, 221 (02) : 100 - 106
  • [6] Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3:: Synthesis and immunosuppressive activity
    Baell, JB
    Gable, RW
    Harvey, AJ
    Toovey, N
    Herzog, T
    Hänsel, W
    Wulff, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (09) : 2326 - 2336
  • [7] Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance
    Upadhyay, Sanjeev Kumar
    Eckel-Mahan, Kristin L.
    Mirbolooki, M. Reza
    Tjong, Indra
    Griffey, Stephen M.
    Schmunk, Galina
    Koehne, Amanda
    Halbout, Briac
    Iadonato, Shawn
    Pedersen, Brian
    Borrelli, Emiliana
    Wang, Ping H.
    Mukherjee, Jogeshwar
    Sassone-Corsi, Paolo
    Chandy, K. George
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (24) : E2239 - E2248
  • [8] Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases
    Bowlby, MR
    Fadool, DA
    Holmes, TC
    Levitan, IB
    JOURNAL OF GENERAL PHYSIOLOGY, 1997, 110 (05): : 601 - 610
  • [9] Engineering a Potent and Specific Blocker of Voltage-Gated Potassium Channel Kv1.3, a Target for Autoimmune Diseases
    Chen, Rong
    Chung, Shin-Ho
    BIOCHEMISTRY, 2012, 51 (09) : 1976 - 1982
  • [10] Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes
    Pennington, M. W.
    Beeton, C.
    Galea, C. A.
    Smith, B. J.
    Chi, V.
    Monaghan, K. P.
    Garcia, A.
    Rangaraju, S.
    Giuffrida, A.
    Plank, D.
    Crossley, G.
    Nugent, D.
    Khaytin, I.
    LeFievre, Y.
    Peshenko, I.
    Dixon, C.
    Chauhan, S.
    Orzel, A.
    Inoue, T.
    Hu, X.
    Moore, R. V.
    Norton, R. S.
    Chandy, K. G.
    MOLECULAR PHARMACOLOGY, 2009, 75 (04) : 762 - 773
12345